Altered expression of connexin subtypes in mesial temporal lobe epilepsy in humans.
OBJECTIVE
The causes of epileptic events remain unclear. Much in vitro and in vivo experimental evidence suggests that gap junctions formed by connexins (Cxs) between neurons and/or astrocytes contribute to the generation and maintenance of seizures; however, few experiments have been conducted in humans, and those completed have shown controversial data. The authors designed a study to compare the level of expression of Cxs in hippocampi from epileptic and nonepileptic patients to assess whether an alteration of gap junction expression in epileptic tissue plays a role in seizure origin and propagation.


METHODS
The expression of Cxs32, -36, and -43 was studied in 47 consecutive samples of hippocampi obtained from epileptic patients who had undergone an amygdalohippocampectomy for the treatment of intractable seizure. These expression levels were compared with those in hippocampi obtained in nonepileptic patients during postmortem dissection. Immunostaining was performed to create one slide for each of the three Cxs. Each slide demonstrated multiple cells from each of six regions (CA1, CA2, CA3, CA4, dentate gyrus, and subiculum). Two independent reviewers rated each Cx-region combination according to an immunoreactive score. Across all three measures-that is, staining intensity, percentage of positively stained cells, and immunoreactive score-Cx32 appeared to be expressed at a significantly lower level in the epileptic patients compared with controls (p < 0.001 for each measure), whereas Cx43 appeared to be expressed more among the epileptic patients (p < 0.001 for each measure). There was no evidence of any differential expression of Cx36. There was, however, regional variation within each Cx subtype. For Cx36, the staining intensity was higher in the CA2 region in the epilepsy group.


CONCLUSIONS
The increase in Cx43, decrease in Cx32, and preservation of Cx36 expression in hippocampi from epileptic persons could play a role in the development of seizures in patients with temporal sclerosis. Additional studies must be completed to understand this mechanism better.
Collignon
Frederic
F
Department of Neurological Surgery, Mayo Clinic, Rochester, Minnesota, USA. frederic_collignon2@hotmail.com
Wetjen
Nicholas M
NM
Cohen-Gadol
Aaron A
AA
Cascino
Gregory D
GD
Parisi
Joseph
J
Meyer
Fredric B
FB
Marsh
W Richard
WR
Roche
Patrick
P
Weigand
Stephen D
SD
D038481:Anterior Temporal Lobectomy; D016022:Case-Control Studies; D017630:Connexins / Q000378:metabolism*; D004833:Epilepsy, Temporal Lobe / Q000378:metabolism* / Q000473:pathology / Q000601:surgery; D017629:Gap Junctions / Q000502:physiology; D006624:Hippocampus / Q000378:metabolism*; D006801:Humans
D017630:Connexins